Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

ConditionGestational Diabetes Mellitus

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-51

SponsorWolfson Medical Center

About this trial

This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.

Eligibility criteria

Qualifiers

Singleton pregnancy

GDM diagnosed by OGTT or glucose monitoring

Hebrew speaking

Compatible cellphone

Disqualifiers

Pregestational diabetes

Fetal anomalies/genetic abnormalities

Multifetal pregnancy

Late GDM diagnosis (after 34 weeks)

Trial design

Treatments tested in this trial

Use of the Pulsenmore home ultrasound device for fetal assessment, guided remotely by a physician.

Treatment groups

90 Participants

are divided into 2 treatment groups

Locations

Edith Wolfson Medical Center5834468, H̱olonCentral District, Israel

Sponsors and collaborators

Wolfson Medical Center

Lead sponsor

PulseNmore

Collaborator

Source ClinicalTrials.gov